NOVALGEN LIMITED
Significant control: Convergys Capital Limited (25–50%), Ghl Capital Ltd (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Novalgen Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Novalgen Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NOVALGEN LIMITED is an active private limited company (company number 11621264) incorporated on 14 October 2018, registered in Northwood Hills. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £3.53m and cash of £1.37m, with 8 employees on average. Net assets fell 9% on the prior period (£3.86m).
By net assets it sits in the top quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
Ownership and control
- Convergys Capital Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Ghl Capital Ltd
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Amit Chunilal Nathwani
- owns 25–50% of shares
- holds 25–50% of voting rights
- Ucl Business Plc
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 14 October 20188 yrs ago
- Next accounts due
- 30 September 2027in 339 days
- Confirmation statement due
- 28 October 2026in 2 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £3.53m | £1.37m | £810k | £1.26m | — | — | 8 |
| 31 December 2024 | £3.86m | £683k | £1.16m | £788k | — | — | 15 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £3,525,355 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.74
- Cash at bank of £50,000 or moreCash £1,369,753
- Incorporated five or more years agoIncorporated 14 October 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 339 days
- Confirmation statement duein 2 days
- Accounts period endNet assets £3.53m · small accounts
- Accounts period endNet assets £3.86m · small accounts
- Incorporated
Similar companies in Greater London
- BIOPOISE CONSULTING LTDDagenham · inc. Oct 2018
- L-BASE LTDChessington · inc. Sept 2018
- HYGEA BLU LTDTilbury · inc. Aug 2018
- V2130 LABS IP LTDRainham · inc. Jul 2018
- J&A HEALTH SOLUTIONS LTDWatford · inc. Jan 2019
- BIOTIP LTDRickmansworth · inc. Jan 2019
All companies incorporated on 14 October 2018 · in Oct 2018.
Reminders for NOVALGEN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.